What we all have in common is our passionate desire to advance science to develop the best therapies for patients with profound unmet medical needs

Entrada Therapeutics is a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics

Headquartered in Boston, Mass., Entrada is a private company that closed on its Series A in December 2018. To date, Entrada has raised over $50 million from 5AM Ventures, MPM Capital, Roche Venture Fund, MRL Ventures Fund and Agent Capital.

At Entrada, we’re tackling a wide range of diseases and targets. Our team is comprised of dedicated experts and leaders focused on advancing our technology platforms to yield treatments for patients in need.

Our Values

  • Humanity

    We genuinely care about patients and about one another

  • Tenacity

    We’re relentless and persistent in the pursuit of developing therapies for patients

  • Creativity

    We’re creative problem solvers

  • Collaboration

    We’re more than the sum of our parts

  • Curiosity

    We’ve got a growth mindset

Join our team if you share our values, our devotion to science and our passion for helping patients.

Current Openings

December 12, 2018
December 12, 2018